Cargando…
PTPN2 targets TAK1 for dephosphorylation to improve cellular senescence and promote adipose tissue browning in T2DM
Introduction: The energy imbalance when energy intake exceeds expenditure acts as an essential factor in the development of insulin resistance (IR). The activity of brown adipose tissue, which is involved in the dissipation of energy via heat expenditure decreases under type 2 diabetic mellitus (T2D...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10213551/ https://www.ncbi.nlm.nih.gov/pubmed/37251330 http://dx.doi.org/10.3389/fphar.2023.1124633 |
_version_ | 1785047645506502656 |
---|---|
author | Liu, Yapeng Han, Lu Zhu, Ping Song, Ming Zhang, Yaoyuan Meng, Linlin Zhang, Wei Zhang, Cheng Zhong, Ming |
author_facet | Liu, Yapeng Han, Lu Zhu, Ping Song, Ming Zhang, Yaoyuan Meng, Linlin Zhang, Wei Zhang, Cheng Zhong, Ming |
author_sort | Liu, Yapeng |
collection | PubMed |
description | Introduction: The energy imbalance when energy intake exceeds expenditure acts as an essential factor in the development of insulin resistance (IR). The activity of brown adipose tissue, which is involved in the dissipation of energy via heat expenditure decreases under type 2 diabetic mellitus (T2DM) state when the number of pathological aging adipocytes increases. Protein tyrosine phosphatase non-receptor type 2 (PTPN2) regulates several biological processes by dephosphorylating several cellular substrates; however, whether PTPN2 regulates cellular senescence in adipocytes and the underlying mechanism has not been reported. Methods: We constructed a model of type 2 diabetic mice with PTPN2 overexpression to explore the role of PTPN2 in T2DM. Results: We revealed that PTPN2 facilitated adipose tissue browning by alleviating pathological senescence, thus improving glucose tolerance and IR in T2DM. Mechanistically, we are the first to report that PTPN2 could bind with transforming growth factor-activated kinase 1 (TAK1) directly for dephosphorylation to inhibit the downstream MAPK/NF-κB pathway in adipocytes and regulate cellular senescence and the browning process subsequently. Discussion: Our study revealed a critical mechanism of adipocytes browning progression and provided a potential target for the treatment of related diseases. |
format | Online Article Text |
id | pubmed-10213551 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-102135512023-05-27 PTPN2 targets TAK1 for dephosphorylation to improve cellular senescence and promote adipose tissue browning in T2DM Liu, Yapeng Han, Lu Zhu, Ping Song, Ming Zhang, Yaoyuan Meng, Linlin Zhang, Wei Zhang, Cheng Zhong, Ming Front Pharmacol Pharmacology Introduction: The energy imbalance when energy intake exceeds expenditure acts as an essential factor in the development of insulin resistance (IR). The activity of brown adipose tissue, which is involved in the dissipation of energy via heat expenditure decreases under type 2 diabetic mellitus (T2DM) state when the number of pathological aging adipocytes increases. Protein tyrosine phosphatase non-receptor type 2 (PTPN2) regulates several biological processes by dephosphorylating several cellular substrates; however, whether PTPN2 regulates cellular senescence in adipocytes and the underlying mechanism has not been reported. Methods: We constructed a model of type 2 diabetic mice with PTPN2 overexpression to explore the role of PTPN2 in T2DM. Results: We revealed that PTPN2 facilitated adipose tissue browning by alleviating pathological senescence, thus improving glucose tolerance and IR in T2DM. Mechanistically, we are the first to report that PTPN2 could bind with transforming growth factor-activated kinase 1 (TAK1) directly for dephosphorylation to inhibit the downstream MAPK/NF-κB pathway in adipocytes and regulate cellular senescence and the browning process subsequently. Discussion: Our study revealed a critical mechanism of adipocytes browning progression and provided a potential target for the treatment of related diseases. Frontiers Media S.A. 2023-05-12 /pmc/articles/PMC10213551/ /pubmed/37251330 http://dx.doi.org/10.3389/fphar.2023.1124633 Text en Copyright © 2023 Liu, Han, Zhu, Song, Zhang, Meng, Zhang, Zhang and Zhong. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Liu, Yapeng Han, Lu Zhu, Ping Song, Ming Zhang, Yaoyuan Meng, Linlin Zhang, Wei Zhang, Cheng Zhong, Ming PTPN2 targets TAK1 for dephosphorylation to improve cellular senescence and promote adipose tissue browning in T2DM |
title | PTPN2 targets TAK1 for dephosphorylation to improve cellular senescence and promote adipose tissue browning in T2DM |
title_full | PTPN2 targets TAK1 for dephosphorylation to improve cellular senescence and promote adipose tissue browning in T2DM |
title_fullStr | PTPN2 targets TAK1 for dephosphorylation to improve cellular senescence and promote adipose tissue browning in T2DM |
title_full_unstemmed | PTPN2 targets TAK1 for dephosphorylation to improve cellular senescence and promote adipose tissue browning in T2DM |
title_short | PTPN2 targets TAK1 for dephosphorylation to improve cellular senescence and promote adipose tissue browning in T2DM |
title_sort | ptpn2 targets tak1 for dephosphorylation to improve cellular senescence and promote adipose tissue browning in t2dm |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10213551/ https://www.ncbi.nlm.nih.gov/pubmed/37251330 http://dx.doi.org/10.3389/fphar.2023.1124633 |
work_keys_str_mv | AT liuyapeng ptpn2targetstak1fordephosphorylationtoimprovecellularsenescenceandpromoteadiposetissuebrowningint2dm AT hanlu ptpn2targetstak1fordephosphorylationtoimprovecellularsenescenceandpromoteadiposetissuebrowningint2dm AT zhuping ptpn2targetstak1fordephosphorylationtoimprovecellularsenescenceandpromoteadiposetissuebrowningint2dm AT songming ptpn2targetstak1fordephosphorylationtoimprovecellularsenescenceandpromoteadiposetissuebrowningint2dm AT zhangyaoyuan ptpn2targetstak1fordephosphorylationtoimprovecellularsenescenceandpromoteadiposetissuebrowningint2dm AT menglinlin ptpn2targetstak1fordephosphorylationtoimprovecellularsenescenceandpromoteadiposetissuebrowningint2dm AT zhangwei ptpn2targetstak1fordephosphorylationtoimprovecellularsenescenceandpromoteadiposetissuebrowningint2dm AT zhangcheng ptpn2targetstak1fordephosphorylationtoimprovecellularsenescenceandpromoteadiposetissuebrowningint2dm AT zhongming ptpn2targetstak1fordephosphorylationtoimprovecellularsenescenceandpromoteadiposetissuebrowningint2dm |